Page 99 - NobleCon21

iHuman Inc.

SELECTED FINANCIAL ITEMS IH
(in millions of USD)
CQ4 '24 CQ1 '25 CQ2 '25 CQ3 '25 LTM
Income Statement Key Items
Total Revenue 34.13 31.88 29.00 27.94 122.95
Gross Profit 23.36 21.43 19.81 18.95 83.56
Gross Margin 68% 67% 68% 68% 68%
EBIT 2.95 2.04 2.98 2.72 10.69
EBIT Margin 9% 6% 10% 10% 9%
Net Income to Common Shareholders 3.58 3.63 3.65 4.45 15.32
Net Margin 11% 11% 13% 16% 12%

Balance Sheet Key Items
Total Assets 202.53 194.50 189.10 186.37 186.37
Cash & Short Term Investments 651.68 1,123.29 1,119.06 605.14 605.14
% of Assets 322% 578% 592% 325% 325%
Current Assets -Total 193.31 183.01 177.68 176.41 176.41
% of Assets 95% 94% 94% 95% 95%
Total Liabilities 494.32 458.80 431.15 365.70 365.70
% of Assets 244% 236% 228% 196% 196%
Current Liabilities - Total 493.58 447.54 420.56 355.69 355.69
% of Assets 244% 230% 222% 191% 191%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 132.06 131.64 129.68 135.32 135.32
% of Assets 65% 68% 69% 73% 73%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities NA NA NA NA 0.00
Net Cash Flow - Investing NA NA NA NA 0.00
Net Cash Flow - Financing NA NA NA NA 0.00

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference